Clinical Trials on Mineralocorticoid Receptor Antagonist in United Kingdom
Total 379 results
-
Daiichi Sankyo, Inc.CompletedHypertension | Mineralocorticoid Receptor AntagonistUnited States
-
AstraZenecaCompleted
-
Vanderbilt University Medical CenterCompletedLung Diseases | Hypertension | Pulmonary Arterial Hypertension | Familial Primary Pulmonary Hypertension | Primary Pulmonary Hypertension | Estrogens | Tamoxifen | Estrogen Receptor Antagonist | Hormone AntagonistsUnited States
-
National Institute of Arthritis and Musculoskeletal...National Institutes of Health Clinical Center (CC)Completed
-
The Royal Wolverhampton Hospitals NHS TrustCompletedApparent Mineralocorticoid ExcessUnited Kingdom
-
National Institute of Mental Health (NIMH)CompletedHealthy | PET Scan | Glutamate Receptor | mGlur5 Protein | Excitatory Amino Acid Receptors | Drug KineticsUnited States
-
Wake Forest University Health SciencesJohns Hopkins UniversityTerminatedHIV | Sarcopenia | Aging | Angiotensin Receptor AntagonistsUnited States
-
Brigham and Women's HospitalCompletedApparent Mineralocorticoid Excess (AME)United States
-
Icahn School of Medicine at Mount SinaiEunice Kennedy Shriver National Institute of Child Health and Human Development... and other collaboratorsCompletedApparent Mineralocorticoid Excess SyndromeUnited States, Brazil, France
-
Food and Drug Administration (FDA)Spaulding Clinical Research LLCCompletedClinical Study to Investigate the Pharmacokinetics of Multiple Repeated Doses of Intranasal NaloxoneHealthy Subjects | Pharmacokinetics | Opioid AntagonistUnited States
-
Houston Fertility InstituteCompletedGnRH Antagonist | Compare Pregnancy Rates Between FSH Stimulation and FSH andUnited States
-
Brigham and Women's HospitalEnrolling by invitationLower Extremity Amputation | Trans-Tibial Amputation | Traumatic Lower Extremity Amputation | Agonist-Antagonist Myoneural InterfaceUnited States
-
Northumbria UniversityWithdrawnBlood Glucose | Appetite | Intestinal Absorption | Nutrient Sensing | Taste ReceptorsUnited Kingdom
-
Rhythm Pharmaceuticals, Inc.CompletedLeptin Receptor Deficiency ObesityNetherlands, Germany, United Kingdom, Canada, France, Réunion
-
Eunice Kennedy Shriver National Institute of Child...CompletedACTH | Glucocorticoid | Cortisol Resistance | Negative Feedback | MineralcorticoidUnited States
-
AstraZenecaCompletedAdvanced Solid Tumours With Androgen Receptor Pathway as a Potential FactorUnited Kingdom, United States
-
Queen Mary University of LondonHoffmann-La Roche; Asan Medical Center; Kliniken Essen-Mitte; MedSIRActive, not recruitingBreast Cancer | Estrogen Receptor-positive Breast CancerUnited Kingdom
-
St George's, University of LondonRecruitingChronic Kidney Diseases | Heart Failure With Reduced Ejection Fraction | Hyperkalemia | ACE Inhibitor Induced Hyperkalaemia | Mineralocorticoid Resistant HyperkalemiaUnited Kingdom
-
Yale UniversityJanssen Scientific Affairs, LLCNot yet recruitingMuscarinic Receptor OccupancyUnited States
-
Colorado State UniversityCompletedReceptor BlockadeUnited States
-
Vanderbilt-Ingram Cancer CenterNational Cancer Institute (NCI); Genentech, Inc.; Translational Breast Cancer... and other collaboratorsTerminatedStage IV Breast Cancer | Estrogen Receptor Negative | Estrogen Receptor Positive | HER2/Neu Negative | Progesterone Receptor Negative | Progesterone Receptor Positive | Triple-Negative Breast CarcinomaUnited States
-
Ellipses PharmaRecruitingMetastatic Breast Cancer | Hormone Receptor-positive Breast Cancer | Hormone Receptor Positive HER-2 Negative Breast CancerUnited States, Spain, United Kingdom
-
National Cancer Institute (NCI)TerminatedStage IV Breast Cancer | Recurrent Breast Carcinoma | Estrogen Receptor Negative | Estrogen Receptor Positive | HER2/Neu Positive | Progesterone Receptor Negative | Progesterone Receptor PositiveUnited States
-
National Institute of Mental Health (NIMH)CompletedBaseline | Blocking Receptor BindingUnited States
-
Brigham and Women's HospitalRecruiting
-
City of Hope Medical CenterNational Cancer Institute (NCI); Merck Sharp & Dohme LLCCompletedStage IV Breast Cancer | Estrogen Receptor Negative | Estrogen Receptor Positive | HER2/Neu Negative | Progesterone Receptor Negative | Progesterone Receptor Positive | Triple-Negative Breast CarcinomaUnited States
-
University of WashingtonNational Cancer Institute (NCI)CompletedHER2-positive Breast Cancer | Stage II Breast Cancer | Stage IIIA Breast Cancer | Stage IA Breast Cancer | Stage IB Breast Cancer | Estrogen Receptor-negative Breast Cancer | Estrogen Receptor-positive Breast Cancer | Progesterone Receptor-negative Breast Cancer | Progesterone Receptor-positive Breast...United States
-
University of PennsylvaniaActive, not recruitingHealthy Volunteer | D3 Dopamine Receptor | Cocaine-dependentUnited States
-
National Institute of Nursing Research (NINR)Not yet recruitingRyanodine Receptor 1-Related Myopathy | Ryanodine Receptor 1 Related DisordersUnited States
-
Novartis PharmaceuticalsCompletedTNF-receptor Associated Periodic Syndromes (TRAPS)United Kingdom, Ireland, Italy
-
National Institute of Mental Health (NIMH)CompletedmGluR5 ReceptorsUnited States
-
SanofiCompletedChronic Heart FailureCanada, United States, United Kingdom
-
Fred Hutchinson Cancer CenterNational Cancer Institute (NCI)CompletedInflammatory Breast Cancer | Male Breast Cancer | Stage IV Breast Cancer | Stage IIIB Breast Cancer | Estrogen Receptor-negative Breast Cancer | Estrogen Receptor-positive Breast Cancer | Progesterone Receptor-negative Breast Cancer | Progesterone Receptor-positive Breast CancerUnited States
-
University of California, Los AngelesTerminatedCognitive Function | Methamphetamine Abuse | Dopamine D2/3 Receptor AvailabilityUnited States
-
The Christie NHS Foundation TrustSahlgrenska University Hospital, SwedenActive, not recruitingBreast Cancer Metastatic | Estrogen Receptor-positive Breast CancerUnited Kingdom, Sweden
-
National Cancer Institute (NCI)CompletedStage IV Breast Cancer | Recurrent Breast Cancer | Estrogen Receptor-positive Breast Cancer | Progesterone Receptor-negative Breast Cancer | Progesterone Receptor-positive Breast CancerUnited States
-
City of Hope Medical CenterNational Cancer Institute (NCI)CompletedEstrogen Receptor Negative | HER2/Neu Negative | Progesterone Receptor Negative | Metastatic Triple-Negative Breast Carcinoma | Stage IV Breast Cancer AJCC v6 and v7 | Androgen Receptor PositiveUnited States
-
National Cancer Institute (NCI)TerminatedStage IIIA Breast Cancer | Stage IIIB Breast Cancer | Stage IA Breast Cancer | Stage IB Breast Cancer | Stage IIA Breast Cancer | Stage IIB Breast Cancer | Stage IIIC Breast Cancer | Estrogen Receptor Negative | Estrogen Receptor Positive | HER2/Neu Negative | HER2/Neu Positive | Progesterone Receptor Negative | Progesterone Receptor Positive and other conditionsUnited States
-
Novartis PharmaceuticalsCompletedOestrogen Receptor Positive Advanced Breast CancerUnited Kingdom
-
AC Camargo Cancer CenterH. Lee Moffitt Cancer Center and Research InstituteCompletedNeuroendocrine Tumors | Estrogen Receptor Positive Tumor | Progesterone Receptor Positive TumorUnited States, Brazil
-
Brigham and Women's HospitalNational Heart, Lung, and Blood Institute (NHLBI)Not yet recruitingHypertension | Primary Aldosteronism | Hyperaldosteronism | Resistant Hypertension | Mineralocorticoid Excess | Secondary HypertensionUnited States
-
Oana Danciu, MDPfizer; Big Ten Cancer Research ConsortiumActive, not recruitingMetastatic Breast Cancer | Hormone Receptor Positive Malignant Neoplasm of Breast | Human Epidermal Growth Factor 2 Negative Carcinoma of Breast | Estrogen Receptor Positive Breast Cancer | Progesterone Receptor Positive TumorUnited States
-
Eisai Inc.CompletedBreast Cancer | Breast Neoplasms | Cancer, Breast | Breast Cancer Female | Estrogen Receptor Positive Tumor | Breast Adenocarcinoma | ER Positive | Estrogen-receptor Positive Breast CancerFrance, United Kingdom, United States
-
Yale UniversityVA Office of Research and DevelopmentCompletedNMDA Receptor FunctionUnited States
-
Adrienne G. WaksEli Lilly and Company; Verastem, Inc.RecruitingBreast Cancer | Hormone Receptor-positive Breast Cancer | Hormone Receptor Positive HER-2 Negative Breast CancerUnited States
-
Eisai Inc.Active, not recruitingBreast Neoplasms | Receptors, Estrogen | Genes, Erbb-2United States, United Kingdom
-
University of Southern CaliforniaTerminatedPregnancy | Cervical Prostaglandin EP3 ReceptorsUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)Active, not recruitingInvasive Breast Carcinoma | Estrogen Receptor Positive | HER2/Neu Negative | Progesterone Receptor PositiveUnited States
-
Velindre NHS TrustAstraZeneca; Cardiff and Vale University Health Board; Covance; Cenduit LLCActive, not recruitingEstrogen Receptor Positive Breast CancerUnited Kingdom
-
City of Hope Medical CenterNational Cancer Institute (NCI)CompletedStage IV Breast Cancer | Estrogen Receptor Negative | HER2/Neu Negative | Triple-negative Breast Carcinoma | Progesterone Receptor-negativeUnited States